Cargando…
Reversible lysine fatty acylation of an anchoring protein mediates adipocyte adrenergic signaling
N-myristoylation on glycine is an irreversible modification that has long been recognized to govern protein localization and function. In contrast, the biological roles of lysine myristoylation remain ill-defined. We demonstrate that the cytoplasmic scaffolding protein, gravin-α/A kinase–anchoring p...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851525/ https://www.ncbi.nlm.nih.gov/pubmed/35149557 http://dx.doi.org/10.1073/pnas.2119678119 |
_version_ | 1784652839624114176 |
---|---|
author | Bagchi, Rushita A. Robinson, Emma L. Hu, Tianjing Cao, Ji Hong, Jun Young Tharp, Charles A. Qasim, Hanan Gavin, Kathleen M. Pires da Silva, Julie Major, Jennifer L. McConnell, Bradley K. Seto, Edward Lin, Hening McKinsey, Timothy A. |
author_facet | Bagchi, Rushita A. Robinson, Emma L. Hu, Tianjing Cao, Ji Hong, Jun Young Tharp, Charles A. Qasim, Hanan Gavin, Kathleen M. Pires da Silva, Julie Major, Jennifer L. McConnell, Bradley K. Seto, Edward Lin, Hening McKinsey, Timothy A. |
author_sort | Bagchi, Rushita A. |
collection | PubMed |
description | N-myristoylation on glycine is an irreversible modification that has long been recognized to govern protein localization and function. In contrast, the biological roles of lysine myristoylation remain ill-defined. We demonstrate that the cytoplasmic scaffolding protein, gravin-α/A kinase–anchoring protein 12, is myristoylated on two lysine residues embedded in its carboxyl-terminal protein kinase A (PKA) binding domain. Histone deacetylase 11 (HDAC11) docks to an adjacent region of gravin-α and demyristoylates these sites. In brown and white adipocytes, lysine myristoylation of gravin-α is required for signaling via β(2)- and β(3)-adrenergic receptors (β-ARs), which are G protein–coupled receptors (GPCRs). Lysine myristoylation of gravin-α drives β-ARs to lipid raft membrane microdomains, which results in PKA activation and downstream signaling that culminates in protective thermogenic gene expression. These findings define reversible lysine myristoylation as a mechanism for controlling GPCR signaling and highlight the potential of inhibiting HDAC11 to manipulate adipocyte phenotypes for therapeutic purposes. |
format | Online Article Text |
id | pubmed-8851525 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | National Academy of Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-88515252022-08-11 Reversible lysine fatty acylation of an anchoring protein mediates adipocyte adrenergic signaling Bagchi, Rushita A. Robinson, Emma L. Hu, Tianjing Cao, Ji Hong, Jun Young Tharp, Charles A. Qasim, Hanan Gavin, Kathleen M. Pires da Silva, Julie Major, Jennifer L. McConnell, Bradley K. Seto, Edward Lin, Hening McKinsey, Timothy A. Proc Natl Acad Sci U S A Biological Sciences N-myristoylation on glycine is an irreversible modification that has long been recognized to govern protein localization and function. In contrast, the biological roles of lysine myristoylation remain ill-defined. We demonstrate that the cytoplasmic scaffolding protein, gravin-α/A kinase–anchoring protein 12, is myristoylated on two lysine residues embedded in its carboxyl-terminal protein kinase A (PKA) binding domain. Histone deacetylase 11 (HDAC11) docks to an adjacent region of gravin-α and demyristoylates these sites. In brown and white adipocytes, lysine myristoylation of gravin-α is required for signaling via β(2)- and β(3)-adrenergic receptors (β-ARs), which are G protein–coupled receptors (GPCRs). Lysine myristoylation of gravin-α drives β-ARs to lipid raft membrane microdomains, which results in PKA activation and downstream signaling that culminates in protective thermogenic gene expression. These findings define reversible lysine myristoylation as a mechanism for controlling GPCR signaling and highlight the potential of inhibiting HDAC11 to manipulate adipocyte phenotypes for therapeutic purposes. National Academy of Sciences 2022-02-11 2022-02-15 /pmc/articles/PMC8851525/ /pubmed/35149557 http://dx.doi.org/10.1073/pnas.2119678119 Text en Copyright © 2022 the Author(s). Published by PNAS. https://creativecommons.org/licenses/by-nc-nd/4.0/This article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Biological Sciences Bagchi, Rushita A. Robinson, Emma L. Hu, Tianjing Cao, Ji Hong, Jun Young Tharp, Charles A. Qasim, Hanan Gavin, Kathleen M. Pires da Silva, Julie Major, Jennifer L. McConnell, Bradley K. Seto, Edward Lin, Hening McKinsey, Timothy A. Reversible lysine fatty acylation of an anchoring protein mediates adipocyte adrenergic signaling |
title | Reversible lysine fatty acylation of an anchoring protein mediates adipocyte adrenergic signaling |
title_full | Reversible lysine fatty acylation of an anchoring protein mediates adipocyte adrenergic signaling |
title_fullStr | Reversible lysine fatty acylation of an anchoring protein mediates adipocyte adrenergic signaling |
title_full_unstemmed | Reversible lysine fatty acylation of an anchoring protein mediates adipocyte adrenergic signaling |
title_short | Reversible lysine fatty acylation of an anchoring protein mediates adipocyte adrenergic signaling |
title_sort | reversible lysine fatty acylation of an anchoring protein mediates adipocyte adrenergic signaling |
topic | Biological Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851525/ https://www.ncbi.nlm.nih.gov/pubmed/35149557 http://dx.doi.org/10.1073/pnas.2119678119 |
work_keys_str_mv | AT bagchirushitaa reversiblelysinefattyacylationofananchoringproteinmediatesadipocyteadrenergicsignaling AT robinsonemmal reversiblelysinefattyacylationofananchoringproteinmediatesadipocyteadrenergicsignaling AT hutianjing reversiblelysinefattyacylationofananchoringproteinmediatesadipocyteadrenergicsignaling AT caoji reversiblelysinefattyacylationofananchoringproteinmediatesadipocyteadrenergicsignaling AT hongjunyoung reversiblelysinefattyacylationofananchoringproteinmediatesadipocyteadrenergicsignaling AT tharpcharlesa reversiblelysinefattyacylationofananchoringproteinmediatesadipocyteadrenergicsignaling AT qasimhanan reversiblelysinefattyacylationofananchoringproteinmediatesadipocyteadrenergicsignaling AT gavinkathleenm reversiblelysinefattyacylationofananchoringproteinmediatesadipocyteadrenergicsignaling AT piresdasilvajulie reversiblelysinefattyacylationofananchoringproteinmediatesadipocyteadrenergicsignaling AT majorjenniferl reversiblelysinefattyacylationofananchoringproteinmediatesadipocyteadrenergicsignaling AT mcconnellbradleyk reversiblelysinefattyacylationofananchoringproteinmediatesadipocyteadrenergicsignaling AT setoedward reversiblelysinefattyacylationofananchoringproteinmediatesadipocyteadrenergicsignaling AT linhening reversiblelysinefattyacylationofananchoringproteinmediatesadipocyteadrenergicsignaling AT mckinseytimothya reversiblelysinefattyacylationofananchoringproteinmediatesadipocyteadrenergicsignaling |